This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB03583/identifier/pdb/
n10http://bio2rdf.org/drugbank:
n4http://linked.opendata.cz/resource/drugbank/drug/DB03583/identifier/pubchem-compound/
n13http://linked.opendata.cz/resource/drugbank/drug/DB03583/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n6http://linked.opendata.cz/resource/drugbank/drug/DB03583/identifier/drugbank/
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n7http://linked.opendata.cz/ontology/drugbank/
n8http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n5http://linked.opendata.cz/resource/drugbank/drug/DB03583/identifier/chemspider/

Statements

Subject Item
n2:DB03583
rdf:type
n7:Drug
n7:group
experimental
owl:sameAs
n10:DB03583 n11:DB03583
dcterms:title
(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One
adms:identifier
n4:5289321 n5:4451312 n6:DB03583 n13:46506569 n14:RYU
n7:IUPAC-Name
n8:271B55DC-363D-11E5-9242-09173F13E4C5
n7:InChI
n8:271B55E2-363D-11E5-9242-09173F13E4C5
n7:Molecular-Formula
n8:271B55E1-363D-11E5-9242-09173F13E4C5
n7:Molecular-Weight
n8:271B55DE-363D-11E5-9242-09173F13E4C5
n7:Monoisotopic-Weight
n8:271B55DF-363D-11E5-9242-09173F13E4C5
n7:SMILES
n8:271B55E0-363D-11E5-9242-09173F13E4C5
n7:Water-Solubility
n8:271B55DA-363D-11E5-9242-09173F13E4C5
n7:logP
n8:271B55D8-363D-11E5-9242-09173F13E4C5 n8:271B55DB-363D-11E5-9242-09173F13E4C5
n7:logS
n8:271B55D9-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Acceptor-Count
n8:271B55E8-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Donor-Count
n8:271B55E9-363D-11E5-9242-09173F13E4C5
n7:InChIKey
n8:271B55E3-363D-11E5-9242-09173F13E4C5
n7:Polar-Surface-Area--PSA-
n8:271B55E4-363D-11E5-9242-09173F13E4C5
n7:Polarizability
n8:271B55E6-363D-11E5-9242-09173F13E4C5
n7:Refractivity
n8:271B55E5-363D-11E5-9242-09173F13E4C5
n7:Rotatable-Bond-Count
n8:271B55E7-363D-11E5-9242-09173F13E4C5
n7:Bioavailability
n8:271B55EE-363D-11E5-9242-09173F13E4C5
n7:Ghose-Filter
n8:271B55F0-363D-11E5-9242-09173F13E4C5
n7:MDDR-Like-Rule
n8:271B55F1-363D-11E5-9242-09173F13E4C5
n7:Number-of-Rings
n8:271B55ED-363D-11E5-9242-09173F13E4C5
n7:Physiological-Charge
n8:271B55EC-363D-11E5-9242-09173F13E4C5
n7:Rule-of-Five
n8:271B55EF-363D-11E5-9242-09173F13E4C5
n7:Traditional-IUPAC-Name
n8:271B55DD-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-acidic-
n8:271B55EA-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-basic-
n8:271B55EB-363D-11E5-9242-09173F13E4C5